Martin Delaney Collaboratories

On June 28, 2010, the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Mental Health (NIMH), both part of the National Institutes of Health, announced a new research funding opportunity to design, develop and evaluate new strategies for curing HIV infection through partnerships among government, industry and academia.

On July 11, 2011, the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health announced that three research teams focused on developing strategies that could help to rid the body of HIV are receiving grants totaling more than $14 million a year, for up to five years.

The DARE collaboratory, led by Drs. Steve Deeks and Mike McCune of UCSF, and Dr. Rafick Sékaly of VGTI-FL, is one of the research teams awarded a grant as part of the NIH Martin Delaney Collaboratory: Towards an HIV-1 Cure initiative.

Other groups funded include:

Find more information about NIAID’s HIV cure research efforts at http://www.niaid.nih.gov/topics/HIVAIDS/Research/cure/Pages/default.aspx

Martin Delaney

Martin DelaneyMartin Delaney (1945-2009) was the Founding Director and public voice of Project Inform, one of the nation’s oldest best-known non-profit foundations working in AIDS. An internationally recognized leader of efforts to provide experimental drugs to seriously ill people prior to FDA approval, his was a key voice in the development of the regulations that today allow accelerated FDA licensure of promising drugs. He was one of the founders of the community-based research movement and, through Project Inform, led the way to the unprecedented level of HIV treatment education available to both for physicians and patients. For 21 years, Mr. Delaney was a constructive critic of federal, academic, and industry AIDS research efforts and a featured voice in the media and at scientific conferences on AIDS-related topics. His writings appeared in such prestigious medical publications as The Journal of Infectious Diseases, Nature, Science and the Journal of AIDS, and in a number of popular magazines.

Martin served on many AIDS-related local and national boards and prominent government advisory panels, including the Department of Health and Human Services HIV Treatment Guidelines Panel, National Academy of Sciences, Institute of Medicine: Roundtable on the Development of Drugs and Vaccines for AIDS, Washington, DC (1988 – 1993), the National Institute of Allergy and Infectious Diseases (NIAID) Council of the National Institutes of Health, the NIAID AIDS Research Advisory Committee and the Board of Advisors of the Institute of Human Virology.

Martin’s work and the history of Project Inform have been described in several books, most prominently in Acceptable Risks, by Jonathan Kwitney, but also in Against the Odds by Peter Arno and Good Intentions by Bruce Nussbaum.

The Martin Delaney Collaboratories were named in Martin’s honor because of his leadership in pushing for funding and structures to support innovative cure research. Martin died of liver cancer in January 2009. His memory lives on in the work that remains.

More About Martin